UBR7 and hepatocellular carcinoma: To address this possibility, gain- and loss-of-function assays were performed in HCC cell lines and corresponding xenografts, and liver-specific UBR7 knockout mice (Alb-Cre; UBR7fl/fl mice) exhibited much faster disease progression, indicating the inhibitory effect of UBR7 on HCC tumorigenesis.